ClinicaliQ Trial Snapshot
- Increasing the Use of an Anti-snoring Mouth Guard (Mandibular Advancement Appliance) to Prevent Upper Airway Collapse During Sleep in Patients With Obstructive Sleep Apnoea. — Recruiting • Non-phase study • Respiratory / COPD / Asthma • NCT04092660.
- What is being tested: Effectiveness of Mandibular Advancement Appliances (MAA/oral appliances) to mechanically prevent upper airway collapse during sleep in obstructive sleep apnoea patients, with a focus on increasing patient uptake and adherence to this treatment modality.
- Patient eligibility overview: Patients with diagnosed obstructive sleep apnoea who are candidates for oral appliance therapy, typically including those with mild-to-moderate OSA or CPAP-intolerant patients, though full eligibility criteria would be specified in the trial protocol.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
Obstructive Sleep Apnoea (OSA) is a sleep-related breathing disorder that is characterized by the repeated collapse of the upper airway during sleep, resulting in sleep deprivation. Mandibular Advancement Appliances (MAA) or Oral Appliances (OA) is prescribed for the patients with OSA and they have been shown to be effective. However, they rely entirely on the patient's acceptance and use. The aim of this study is to assess whether interventions- additional support approaches, will help patients use their MAA more as compared to those who receive routine care. The investigators also…
Eligibility Snapshot
- : * Adult (≥ 40 years old) * Confirmed diagnosis of OSA (AHI ≥ 5) * Referred for MAA therapy * Must be able to understand, read and write English; with the assistance of a translator
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.